Asia Pacific Immunodiagnostics Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Immunodiagnostics Market – by Product

1.3.2 Asia Pacific Immunodiagnostics Market – by Clinical Indication

1.3.3 Asia Pacific Immunodiagnostics Market – by End User

1.3.4 Asia Pacific Immunodiagnostics Market – by Country

2. Asia Pacific Immunodiagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Immunodiagnostics Market – Market Landscape

4.1 Overview

4.2 Asia Pacific PEST Analysis

4.3 Expert’s Opinion

5. Asia Pacific Immunodiagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Infectious Diseases

5.1.2 Growing Use of Point-of-Care Immunodiagnostics

5.2 Market Restraints

5.2.1 Inadequate Reimbursement Scenario

5.3 Market Opportunities

5.3.1 Rising Focus on R&D Investment and Expansion by Key Players

5.4 Future Trends

5.4.1 Technological Advancements in Immunodiagnostics

5.5 Impact Analysis

6. Immunodiagnostics Market – Asia Pacific Analysis

6.1 Asia Pacific Immunodiagnostics Market Revenue Forecast and Analysis

7. Asia Pacific Immunodiagnostics Market Analysis – by Product

7.1 Overview

7.2 Asia Pacific Immunodiagnostics Market, By Product, 2022 & 2030 (%)

7.3 Enzyme-linked Immunosorbent Assays (ELISA)

7.3.1 Overview

7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4 Chemiluminescence Immunoassays (CLIA)

7.4.1 Overview

7.4.2 Chemiluminescence Immunoassays (CLIA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.3 Vitamin D Assay

7.4.3.1 Overview

7.4.3.2 Vitamin D Assay: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.4 HIV Detection

7.4.4.1 Overview

7.4.4.2 HIV Detection: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.5 HIV Ag/Ab Combo assay

7.4.5.1 Overview

7.4.5.2 HIV Ag/Ab Combo Assay: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.4.6 Other Tests

7.4.6.1 Overview

7.4.6.2 Other Tests: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.5 Radioimmunoassays (RIA)

7.5.1 Overview

7.5.2 Radioimmunoassays (RIA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Immunodiagnostics Market Analysis – Clinical Indication

8.1 Overview

8.2 Asia Pacific Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)

8.3 Infectious Diseases:

8.3.1 Overview

8.3.2 Infectious Diseases: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.1 COVID-19

8.3.2.1.1 Overview

8.3.2.1.2 COVID-19: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.2 Tuberculosis

8.3.2.2.1 Overview

8.3.2.2.2 Tuberculosis: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.3 Lyme

8.3.2.3.1 Overview

8.3.2.3.2 Lyme: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.4 Infection Management

8.3.2.4.1 Overview

8.3.2.4.2 Infection Management: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.5 Zika

8.3.2.5.1 Overview

8.3.2.5.2 Zika: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.6 Treponema

8.3.2.6.1 Overview

8.3.2.6.2 Treponema: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.7 TORCH

8.3.2.7.1 Overview

8.3.2.7.2 TORCH: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.8 Measles and Mumps

8.3.2.8.1 Overview

8.3.2.8.2 Measles and Mumps: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.9 VZV

8.3.2.9.1 Overview

8.3.2.9.2 VZV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.3.2.10 EBV

8.3.2.10.1 Overview

8.3.2.10.2 EBV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.4 Hepatitis+HIV:

8.4.1 Overview

8.4.2 Hepatitis+HIV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.5 Gastrointestinal

8.5.1 Overview

8.5.2 Gastrointestinal: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.6 Metabolic Disorders

8.6.1 Overview

8.6.2 Metabolics: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7 Endocrinology

8.7.1 Overview

8.7.2 Endocrinology: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.3 Hypertension

8.7.3.1 Overview

8.7.3.2 Hypertension: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.4 Growth

8.7.4.1 Overview

8.7.4.2 Growth: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.5 Diabetes

8.7.5.1 Overview

8.7.5.2 Diabetes: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.6 Thyroid

8.7.6.1 Overview

8.7.6.2 Thyroid: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.7.7 Reproductive Endocrinology

8.7.7.1 Overview

8.7.7.2 Reproductive Endocrinology: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Immunodiagnostics Market Analysis – End User

9.1 Overview

9.2 Asia Pacific Immunodiagnostics Market Share by End User - 2022 & 2030 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.5 Diagnostic Laboratories

9.5.1 Overview

9.5.2 Diagnostic Laboratories: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.6 Academic and Research Institutes

9.6.1 Overview

9.6.2 Academic and Research Institutes: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 – Country Analysis

10.1 Overview

10.1.1.1 China: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 China: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3 China: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.1.3.1 China: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4 China: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4.1 China: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.4.2 China: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.5 China: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.2 Japan: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Japan: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 Japan: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.2.3.1 Japan: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4 Japan: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4.1 Japan: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.4.2 Japan: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.5 Japan: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.3 India: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 India: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 India: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.3.3.1 India: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4 India: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4.1 India: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.4.2 India: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.5 India: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.4 Australia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Australia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.3 Australia: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.4.3.1 Australia: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.4 Australia: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.4.1 Australia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.4.2 Australia: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.5 Australia: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.5 South Korea: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 South Korea: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.3 South Korea: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.5.3.1 South Korea: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.4 South Korea: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.4.1 South Korea: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.4.2 South Korea: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.5 South Korea: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.1.6 Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.3 Rest of Asia Pacific: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)

10.1.1.6.3.1 Rest of Asia Pacific: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.4 Rest of Asia Pacific: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.4.1 Rest of Asia Pacific: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.4.2 Rest of Asia Pacific: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.5 Rest of Asia Pacific: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)

11. Asia Pacific Immunodiagnostics Market –Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Abbott Laboratories

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F. Hoffmann-La Roche Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 DiaSorin SpA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Danaher Corp

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Thermo Fisher Scientific Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 PerkinElmer Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 bioMerieux SA

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Svar Life Science AB

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Siemens Healthcare GmbH

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. China Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 2. China Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 3. China Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 4. China Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 5. China Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 6. China Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 7. Japan Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 8. Japan Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 9. Japan Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 10. Japan: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 11. Japan Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 12. Japan Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 13. India Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 14. India Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 15. India Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 16. India: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 17. India Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 18. India Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 19. Australia Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 20. Australia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 21. Australia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 22. Australia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 23. Australia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 24. Australia Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 25. South Korea Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 26. South Korea Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 27. South Korea Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 28. South Korea: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 29. South Korea Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 30. South Korea Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 31. Rest of Asia Pacific Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 32. Rest of Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)

Table 33. Rest of Asia Pacific Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)

Table 34. Rest of Asia Pacific: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)

Table 35. Rest of Asia Pacific Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)

Table 36. Rest of Asia Pacific Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 37. Recent Inorganic Growth Strategies in the Asia Pacific immunodiagnostics market

Table 38. Recent Organic Growth Strategies in the Asia Pacific immunodiagnostics market

Table 39. Glossary of Terms, Asia Pacific Immunodiagnostics Market

LIST OF FIGURES

Figure 1. Asia Pacific Immunodiagnostics Market Segmentation

Figure 2. Asia Pacific Immunodiagnostics Market, by Country

Figure 3. Asia Pacific Immunodiagnostics Market Overview

Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in Asia Pacific Immunodiagnostics Market

Figure 5. India Expected to Show Remarkable Growth During Forecast Period

Figure 6. Asia Pacific: PEST Analysis

Figure 7. Experts’ Opinion

Figure 8. Asia Pacific Immunodiagnostics Market: Impact Analysis of Drivers and Restraints

Figure 9. Asia Pacific Immunodiagnostics Market – Revenue Forecast and Analysis – 2021–2030

Figure 10. Asia Pacific Immunodiagnostics Market, by Product, 2022 & 2030 (%)

Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 12. Chemiluminescence Immunoassays (CLIA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 13. Vitamin D Assay: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 14. HIV Detection: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 15. HIV Ag/Ab Combo Assay: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 16. Other Tests: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 17. Radioimmunoassays (RIA):Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 18. Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 19. Asia Pacific Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)

Figure 20. Infectious Diseases: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 21. COVID-19: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 22. Tuberculosis: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 23. Lyme: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 24. Infection Management: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 25. Zika: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 26. Treponema: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 27. TORCH: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 28. Measles and Mumps: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 29. VZV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 30. EBV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 31. Hepatitis+HIV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 32. Gastrointestinal: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 33. Metabolics: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 34. Endocrinology: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 35. Hypertension: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 36. Growth: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 37. Diabetes: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 38. Thyroid: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 39. Reproductive Endocrinology: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 40. Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Figure 41. Asia Pacific Immunodiagnostics Market Share by End User - 2022 & 2030 (%)

Figure 42. Hospitals: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 43. Clinics: Asia Pacific Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)

Figure 44. Diagnostic Laboratories: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 45. Academic and Research Institutes: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 46. Others: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)

Figure 47. Asia Pacific: Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 48. Asia Pacific: Immunodiagnostics Market, by Country, 2022 & 2030 (%)

Figure 49. China: Immunodiagnostics market – Revenue and Forecast to 2030 (US$ Million)

Figure 50. Japan: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 51. India: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 52. Australia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 53. South Korea: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 54. Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)